| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 08/06/2003 | EP1332131A2 Acid derivatives useful as serine protease inhibitors |
| 08/06/2003 | EP1332128A1 Benzamidine derivatives comprising a sulfate group serving as ltb4 antagonists |
| 08/06/2003 | EP1331946A2 Synergistic medicament containing aromatic agents and having an antagonistic, regenerative and/or protagonist decontamination effect |
| 08/06/2003 | EP1331943A2 Nucleic acid molecules and polypeptides for immune modulation |
| 08/06/2003 | EP1331939A1 Murraya koenigii extracts for treating asthma |
| 08/06/2003 | EP1331932A2 Therapeutic uses for ip 3? receptor-mediated calcium channel modulators |
| 08/06/2003 | EP1200070B1 Ambroxol-containing lozenge |
| 08/06/2003 | EP1165544B1 Substituted 1,4-dihydroindeno[1,2-c]pyrazoles as inhibitors of tyrosine kinase |
| 08/06/2003 | EP1090022B1 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives |
| 08/06/2003 | EP1077684B1 Effervescent preparations |
| 08/06/2003 | EP1005328B1 Composition comprising finely divided, crystalline particles of budesonide |
| 08/06/2003 | EP0983064B1 PYRROLES AS sPLA2 INHIBITORS |
| 08/06/2003 | EP0874800B1 Indane dimer compounds with smooth muscle relaxing and/or mast cell stabilising and/or antiinflammatory activity |
| 08/06/2003 | EP0865419B1 Indane dimer compounds and their pharmaceutical use |
| 08/06/2003 | EP0804465B1 Novel elastase inhibitors |
| 08/06/2003 | EP0804419B1 Quinoline derivatives as tachykinin nk 3 receptor antagonists |
| 08/06/2003 | CN1434830A 2-aminocarbonyl-9H-punine derivatives |
| 08/06/2003 | CN1434827A 新的哌啶和哌嗪衍生物 The new piperidine and piperazine derivatives |
| 08/06/2003 | CN1434823A 3-thiazol-4-yl-pyprolidine derivatives as AMP-specific phosphodiesterase inhibitors |
| 08/06/2003 | CN1434820A Cyclic AMP-specific phosphodiesterase inhibitors |
| 08/06/2003 | CN1434818A Novel compounds |
| 08/06/2003 | CN1434817A Pyrazole cyclic AMP-specific PDE inhibitors |
| 08/06/2003 | CN1434813A Pyrrolidine derivatives cyclic AMP-specific phosphodiesterase inhibitors |
| 08/06/2003 | CN1434812A Thizaolyl amide derivatives |
| 08/06/2003 | CN1434811A New p2†ù7 receptor antagonists for use in the treatment of inflammatory immune or cardiovascular diseases |
| 08/06/2003 | CN1434810A Piperidinyloxy and pyrrolidinyloxyphenyl oxazolidiones as antibacterials |
| 08/06/2003 | CN1434805A 选择性神经激肽拮抗剂 Selective neurokinin antagonists |
| 08/06/2003 | CN1434801A Substited 8-anylquinoline phosphodiesterase-4 inhibitors |
| 08/06/2003 | CN1434799A Cyclic amp-specific phosphodiesterase inhibitors |
| 08/06/2003 | CN1434798A Pyrrolidines which inhibit CAMP-specific PDE |
| 08/06/2003 | CN1434797A Hydrazone and oxime derivatives of pyrrolidine as AMP-specific phosphodiesterase inhibitons |
| 08/06/2003 | CN1434794A Adamantane derivatives |
| 08/06/2003 | CN1434712A Nitrosated and nitrosylated cyclooxygenase-2 inhibitors compositions and methods of use |
| 08/06/2003 | CN1434705A Use of hydroxide-releasing agents as skin permeation enhancers |
| 08/06/2003 | CN1434704A System and method for extended delivery of therapeutic agent with its receptor loading dose |
| 08/06/2003 | CN1434701A Y-IFN liquid-droplet aerosol and method |
| 08/06/2003 | CN1433810A Compound liquorice lozenge and preparation process thereof |
| 08/06/2003 | CN1433792A Traditional Chinese medicine for treating child pneumonia |
| 08/06/2003 | CN1433770A Use of BCG polysaccharide and Nucleic acid preparation in preparation of medicine for oral cavity local medication |
| 08/06/2003 | CN1433757A Use of potassium dehydroandrographolide succinate in preparing oral cavity local applied medicine for treating plaryngitis |
| 08/06/2003 | CN1433712A Technological process for preparing beverage, oral liquor electuar, and antitoxic tablet from fern root |
| 08/06/2003 | CN1117090C N-acryl-2-substituted-4-(benzimidazolyl-or-imidazopyridinyl-substituted pesidues)-piperidines as tachykinin antagonists |
| 08/06/2003 | CN1117079C Substituted isoquinoline-3-formamides compounds, its preparing method and its use as medicine |
| 08/06/2003 | CN1117077C 6-phenylpyridyl-2-amine derivatives useful asNOS inhibitors |
| 08/06/2003 | CN1116895C Medical capsule for treating nasosinusitis |
| 08/05/2003 | US6603031 Vitamin D derivatives with cyclic substructures in the side chains, process and intermediate products for their production, and the use for the production of pharmaceutical agents |
| 08/05/2003 | US6603012 RAR selective retinoid agonists |
| 08/05/2003 | US6603008 Sulfamoylheleroaryl pyrazole compounds as anti-inflammatory/analgesic agents |
| 08/05/2003 | US6602914 Treatment of a disease that is mediated by the expression or suppression of a redox sensitive gene, for example MCP-1, IL-6 and thrombin receptor; antiinflammatory agents; cardio-vascular disorders; atherosclerosis; immunology |
| 08/05/2003 | US6602898 Tricyclic fused heterocycle compounds, process for preparing the same and use thereof |
| 08/05/2003 | US6602890 N-(3,5-dichloropyridin-4-yl)-2-(1-(4-fluorobenzyl)-5 -hydroxyindol-3-yl)-2-oxoacetamide, for example; treating eosinophil-related conditions, including chronic obstructive pulmonary disease |
| 08/05/2003 | US6602881 Anti-inflammatory uses of manzamines |
| 08/05/2003 | US6602877 Imidazolyl-cyclic acetals |
| 08/05/2003 | US6602872 Substituted pyridazines having cytokine inhibitory activity |
| 08/05/2003 | US6602850 Method of treating asthma using soluble IL-9 receptor variants |
| 08/05/2003 | US6602707 Mammalian cell surface DNA receptor-encoding nucleic acid |
| 08/05/2003 | US6602667 Of given sequence; useful for diagnosis, prognosis, treatment of inflammatory disorders; screening to identify ligands which bind the polynucleotides |
| 08/05/2003 | US6602509 Compound and method for the prevention and/or the treatment of allergy |
| 08/05/2003 | US6602503 Complementarity determining regions (CDRs); asthma and inflammatory bowel disease; integrins; antigen binding regions derived from the heavy and/ or light chain variable regions |
| 08/05/2003 | CA2362917C Methods for anti-tumor therapy |
| 08/05/2003 | CA2079374C (bicyclic-azaarylmethoxy)indoles as inhibitors of leukotriene biosynthesis |
| 07/31/2003 | WO2003062426A1 Novel protein, its dna and use thereof |
| 07/31/2003 | WO2003062392A2 Methods of treating conditions associated with an edg receptor |
| 07/31/2003 | WO2003062390A2 Compositions and methods for the modulation of sphingolipid metabolism and/or signaling |
| 07/31/2003 | WO2003062370A2 Multimeric proteins and methods of making and using same |
| 07/31/2003 | WO2003062278A1 MONOCLONAL ANTIBODIES AGAINST EXTRACELLULAR LOOPS OF C5aR |
| 07/31/2003 | WO2003062275A1 Glycoisoforms of adiponectin and uses thereof |
| 07/31/2003 | WO2003062274A1 Novel proteins and dnas thereof |
| 07/31/2003 | WO2003062252A1 Edg receptor agonists |
| 07/31/2003 | WO2003062248A2 N-(benzyl)aminoalkylcarboxylates, phosphinates, phosphonates and tetrazoles as edg receptor agonists |
| 07/31/2003 | WO2003062245A1 Fused bicyclic pyrimidine derivatives |
| 07/31/2003 | WO2003062240A1 Pteridine derivatives, method for the production thereof, and use thereof |
| 07/31/2003 | WO2003062227A1 Rho-kinase inhibitors |
| 07/31/2003 | WO2003062225A1 Pyrimidine derivatives as rho-kinase inhibitors |
| 07/31/2003 | WO2003062220A1 N-oxyde of n-phenyl-2-pyrimidine-amine derivatives |
| 07/31/2003 | WO2003062209A2 Substituted quinazolin-4-ylamine analogues as modulators of capsaicin |
| 07/31/2003 | WO2003062203A1 Method |
| 07/31/2003 | WO2003062200A2 Fluoro substituted cycloalkanoindoles and their use as prostaglandin d2 receptor antagonists |
| 07/31/2003 | WO2003061767A1 Methods and compositions for the treatment of asthma and related disorders |
| 07/31/2003 | WO2003061699A1 Remedies for allergic diseases |
| 07/31/2003 | WO2003061668A1 Use of pulmonary surfactant for the prevention of infectious diseases |
| 07/31/2003 | WO2003061659A1 Treating stress response with chemokine receptor ccr5 modulators |
| 07/31/2003 | WO2003061637A1 Compositions for pulmonary administration |
| 07/31/2003 | WO2003061587A2 USE OF TGF-β ANTAGONISTS TO TREAT OR TO PREVENT CHRONIC TRANSPLANT REJECTION |
| 07/31/2003 | WO2003061365A2 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof |
| 07/31/2003 | WO2003041649A3 Cyanoalkylamino derivatives as protease inhibitors |
| 07/31/2003 | WO2003035679A3 Molecules |
| 07/31/2003 | WO2003035668A3 Novel anti-inflammatory androstane derivatives -17-carboxy-lactone substituted steroids with an aryl-carboxylic ester in position 17.alpha |
| 07/31/2003 | WO2003026615A3 Modified release dosage forms |
| 07/31/2003 | WO2003018545B1 24-sulfur-substituted analogs of 1α,25-dihydroxy vitamin d¿3? |
| 07/31/2003 | WO2003006016A3 Use of nk-1 receptor antagonists with pyridinic structure, for the treatment of brain, spinal or nerve injury |
| 07/31/2003 | WO2002098912A3 Guanylate-cyclase c ligand, administered via the airways, for the treatment of respiratory airway problems |
| 07/31/2003 | WO2002068421A3 Tricyclic compounds and their analogs as inhibitors of cytokine signaling |
| 07/31/2003 | WO2002062762A3 Potassium channel openers |
| 07/31/2003 | WO2002060875A8 Nicotinamide biaryl derivatives useful as inhibitors of pde4 isozymes |
| 07/31/2003 | WO2002029038A3 Novel proteins and nucleic acids encoding same and antibodies directed against these proteins |
| 07/31/2003 | US20030144529 Treating p38 kinase mediated disorders. Compounds of particular interest are defined by Formula I Mitogen-activated protein kinases (MAP) is a family of proline- directed serine/threonine kinases that activate their |
| 07/31/2003 | US20030144510 Preparation of pharmaceutical salts |
| 07/31/2003 | US20030144350 Modulating fatty acid or triglyceride accumulation by cells; treating obesity and metabolic disorders |
| 07/31/2003 | US20030144334 Cyclopentabenzofuran derivatives and their use |